Company Disclosure
Lord's Mark Industries Limited (Scrip Code: 501261) has submitted a regulatory filing under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, dated August 10, 2026.
Nature of Event
The company has become the first and only company in India to receive a manufacturing licence for an In Vitro Diagnostic Software (Software as a Medical Device - SaMD) for its Biomescan Analytics Platform.
Regulatory Details
The licence has been granted under the Medical Devices Rules, 2017, specifically classifying the platform as a wellness and health-information tool for preventive healthcare and early health risk assessment.
Platform Technical Specifications
The Biomescan platform combines whole metagenome sequencing data with a validated bioinformatics pipeline to generate:
- Detailed gut microbiome profiles
- Diversity scores
- Enterotype classification
- Functional metabolic assessments
- Evidence-based personalized dietary recommendations
Strategic Expansion Plans
The company plans to establish a nationwide network of Health & Wellness Centres in collaboration with hospitals, doctors, and healthcare institutions to provide personalized microbiome assessments and preventive care strategies.
Management Commentary
Mr. Sachidanand Upadhyay, Managing Director (DIN: 01631728), stated: "Healthcare is moving from reactive treatment to proactive prevention. Our vision is to empower every individual with scientific insights into their own health before disease develops. Biomescan represents a new era where genomics and nutrition come together to create truly personalized wellness. Through partnerships with hospitals and medical professionals across India, we aim to make preventive healthcare accessible, affordable and impactful for millions."
Additional Corporate Information
The company was formerly known as Lords Mark India Limited and Kratos Energy & Infrastructure Limited.